Hydroxychloroquine Concept

Vocabulary Service

MeSH

Overview

subject area of

A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus Academic Article
A living WHO guideline on drugs to prevent covid-19 Academic Article
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Academic Article
A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA study Academic Article
A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial Academic Article
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Academic Article
Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine: First Case Report in Canada and Review of the Literature Academic Article
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials Academic Article
Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI Academic Article
Antithrombotic Drugs Academic Article
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Academic Article
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine Academic Article
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. Academic Article
Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Academic Article
Drug treatments for covid-19: living systematic review and network meta-analysis Academic Article
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs Academic Article
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 Academic Article
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Academic Article
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society Academic Article
How trustworthy guidelines can impact outcomes Academic Article
Hydroxychloroquine attenuates cigarette smoke induced autophagic signaling in the mouse ovary Academic Article
Hydroxychloroquine in Systemic Lupus Erythematosus Academic Article
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 Academic Article
Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus Academic Article
Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent Academic Article
Interventions for cutaneous disease in systemic lupus erythematosus Academic Article
PLATELET SUPPRESSIVE THERAPY Academic Article
Platelet inhibitors in the treatment of thrombosis. Academic Article
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk Academic Article
Prophylaxis against covid-19: living systematic review and network meta-analysis Academic Article
Prophylaxis for COVID-19: a systematic review Academic Article
Psoriasis in systemic lupus erythematosus: a single-center experience Academic Article
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) Academic Article
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update Academic Article
The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis Academic Article
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19 Academic Article
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial Academic Article
The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials Academic Article
The influence of therapy on CD4+CD25^highFOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study Academic Article
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus Academic Article
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Academic Article
Trials and tribulations: so many potential treatments, so few answers Academic Article
Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article
Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Academic Article
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection? Academic Article